Allorion Therapeutics
PrivateLast Round
Series B
Mar 9, 2023
Total Funding Raised
$105M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Allorion Therapeutics is a biopharmaceutical company that develops innovative small-molecule drugs aimed at treating cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allorion Therapeutics Comparables
Compare Allorion Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avenzo Therapeutics | 84% | |
| NiKang Therapeutics | 84% | |
| AnHorn Medicines | 83% |
Allorion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 9, 2023 | ||||
| Series A | Nov 24, 2021 | ||||
| Angel | Jul 1, 2020 |
Key People
Founding team and executive leadership
Allorion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longriver Investment Partners | Series B |
| IDG Capital | Series A |
| Firstred Capital | Series A |
| TF Capital | Angel, Series A, Series B |
| 渶策资本 | Series B |
| Elikonventure.com | Series A, Series B |
| LongRiver Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 50% MoM.
- Jul 27, 2026
Monthly visitors grew 137% MoM, reaching 2.1K.
Allorion Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Allorion Therapeutics's valuation, stock price, and market status.
Is Allorion Therapeutics a public or private company?
Allorion Therapeutics is a private company.
What is the current stock price of Allorion Therapeutics?
Allorion Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Allorion Therapeutics worth (valuation)?
Valuation information for Allorion Therapeutics is not publicly available.
Can I buy Allorion Therapeutics stock?
Allorion Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Allorion Therapeutics's last funding round?
Allorion Therapeutics's most recent funding round was Series B on March 9, 2023.
Who are the main investors in Allorion Therapeutics?
Key investors in Allorion Therapeutics include 渶策资本, Qiming Venture Partners.
Will Allorion Therapeutics IPO soon?
No public IPO plans have been announced for Allorion Therapeutics.
How can I track Allorion Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Allorion Therapeutics's secondary market activity and sign up for updates.